These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 8897265)

  • 1. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization.
    Loftsson T; Brewster ME
    J Pharm Sci; 1996 Oct; 85(10):1017-25. PubMed ID: 8897265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclodextrins in pharmaceutical formulations II: solubilization, binding constant, and complexation efficiency.
    Jambhekar SS; Breen P
    Drug Discov Today; 2016 Feb; 21(2):363-8. PubMed ID: 26687191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclodextrins in pharmaceutical formulations I: structure and physicochemical properties, formation of complexes, and types of complex.
    Jambhekar SS; Breen P
    Drug Discov Today; 2016 Feb; 21(2):356-62. PubMed ID: 26686054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclodextrins as pharmaceutical solubilizers.
    Brewster ME; Loftsson T
    Adv Drug Deliv Rev; 2007 Jul; 59(7):645-66. PubMed ID: 17601630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cyclodextrin solubilization of drugs.
    Loftsson T; Hreinsdóttir D; Másson M
    Int J Pharm; 2005 Sep; 302(1-2):18-28. PubMed ID: 16099118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dramatic improvement of the solubility of pseudolaric acid B by cyclodextrin complexation: preparation, characterization and validation.
    Chi L; Liu R; Guo T; Wang M; Liao Z; Wu L; Li H; Wu D; Zhang J
    Int J Pharm; 2015 Feb; 479(2):349-56. PubMed ID: 25575474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclodextrins in drug delivery.
    Loftsson T; Jarho P; Másson M; Järvinen T
    Expert Opin Drug Deliv; 2005 Mar; 2(2):335-51. PubMed ID: 16296758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-assembled cyclodextrin aggregates and nanoparticles.
    Messner M; Kurkov SV; Jansook P; Loftsson T
    Int J Pharm; 2010 Mar; 387(1-2):199-208. PubMed ID: 19963052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-assembly of cyclodextrin complexes: aggregation of hydrocortisone/cyclodextrin complexes.
    Messner M; Kurkov SV; Brewster ME; Jansook P; Loftsson T
    Int J Pharm; 2011 Apr; 407(1-2):174-83. PubMed ID: 21237259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cyclodextrins on the chemical stability of drugs.
    Popielec A; Loftsson T
    Int J Pharm; 2017 Oct; 531(2):532-542. PubMed ID: 28596139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-association of cyclodextrins and cyclodextrin complexes.
    Loftsson T; Másson M; Brewster ME
    J Pharm Sci; 2004 May; 93(5):1091-9. PubMed ID: 15067686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclodextrins as functional excipients: methods to enhance complexation efficiency.
    Loftsson T; Brewster ME
    J Pharm Sci; 2012 Sep; 101(9):3019-32. PubMed ID: 22334484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical techniques for characterization of cyclodextrin complexes in aqueous solution: a review.
    Mura P
    J Pharm Biomed Anal; 2014 Dec; 101():238-50. PubMed ID: 24680374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of water-soluble polymers on naproxen complexation with natural and chemically modified beta-cyclodextrins.
    Faucci MT; Mura P
    Drug Dev Ind Pharm; 2001 Oct; 27(9):909-17. PubMed ID: 11763468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclodextrins.
    Kurkov SV; Loftsson T
    Int J Pharm; 2013 Aug; 453(1):167-80. PubMed ID: 22771733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inclusion complexes of azadirachtin with native and methylated cyclodextrins: solubilization and binding ability.
    Liu Y; Chen GS; Chen Y; Lin J
    Bioorg Med Chem; 2005 Jun; 13(12):4037-42. PubMed ID: 15911316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclodextrins: structure, physicochemical properties and pharmaceutical applications.
    Jansook P; Ogawa N; Loftsson T
    Int J Pharm; 2018 Jan; 535(1-2):272-284. PubMed ID: 29138045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Amphiphilic cyclodextrins and their applications. Preparation of nanoparticles based on amphiphilic cyclodextrins for biomedical applications].
    Parrot-Lopez H; Perret F; Bertino-Ghera B
    Ann Pharm Fr; 2010 Jan; 68(1):12-26. PubMed ID: 20176159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing the cyclodextrin complexation of drugs and drug biovailability through addition of water-soluble polymers.
    Loftsson T
    Pharmazie; 1998 Nov; 53(11):733-40. PubMed ID: 9853355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug/cyclodextrin/hydroxy acid multicomponent systems. Properties and pharmaceutical applications.
    Redenti E; Szente L; Szejtli J
    J Pharm Sci; 2000 Jan; 89(1):1-8. PubMed ID: 10664533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.